WO2001035863A9 - Modular endoluminal stent having matched stiffness regions - Google Patents
Modular endoluminal stent having matched stiffness regionsInfo
- Publication number
- WO2001035863A9 WO2001035863A9 PCT/US2000/031374 US0031374W WO0135863A9 WO 2001035863 A9 WO2001035863 A9 WO 2001035863A9 US 0031374 W US0031374 W US 0031374W WO 0135863 A9 WO0135863 A9 WO 0135863A9
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- region
- stent
- properties
- flexible
- transition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/064—Blood vessels with special features to facilitate anastomotic coupling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
- A61F2002/067—Y-shaped blood vessels modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0058—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0036—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
Definitions
- TECHNICAL FIELD This invention relates generally to endoluminal grafts or prostheses and, more specifically, to a prosthesis having regions of different stiffness.
- a stent is an elongated device used to support an intraluminal wall.
- a stent provides an unobstructed conduit for blood in the area of the stenosis.
- Such a stent may also have a prosthetic graft layer of fabric or covering lining the inside or outside thereof, such a covered stent being commonly referred to in the art as an intraluminal prosthesis, an endoluminal or endovascular graft (EVG), or a stent-graft.
- EVG endoluminal or endovascular graft
- a prosthesis may be used, for example, to treat a vascular aneurysm by removing the pressure on a weakened part of an artery so as to reduce the risk of rupture.
- a prosthesis is implanted in a blood vessel at the site of a stenosis or aneurysm endoluminally, i.e. by so-called “minimally invasive techniques” in which the prosthesis, maintained in a radially compressed configuration by a sheath or catheter, is delivered by a deployment system or "introducer" to the site where it is required.
- the introducer may enter the body through the patient's skin, or by a "cut down" technique in which the entry blood vessel is exposed by minor surgical means.
- the introducer When the introducer has been advanced into the body lumen to the prosthesis deployment location, the introducer is manipulated to cause the prosthesis to be deployed from the surrounding sheath or catheter in which it is maintained (or alternatively the surrounding sheath or catheter is retracted from the prosthesis), whereupon the prosthesis expands to a predetermined diameter at the deployment location, and the introducer is withdrawn.
- Stent expansion may be effected by spring elasticity, balloon expansion, or by the self-expansion of a thermally or stress- induced return of a memory material to a pre-conditioned expanded configuration.
- a bifurcated modular stent 10 adapted to treat abdominal aortic aneurysms comprises two components: a bifurcated component 12 comprising a trunk section 14 with an attached or unibody fixed ipsilateral iliac leg (IIL) 16 and a socket 18, and a second component 20 that comprises the adjoining contralateral iliac leg (CIL).
- a bifurcated component 12 comprising a trunk section 14 with an attached or unibody fixed ipsilateral iliac leg (IIL) 16 and a socket 18, and a second component 20 that comprises the adjoining contralateral iliac leg (CIL).
- IIL ipsilateral iliac leg
- CIL contralateral iliac leg
- interface section 19 between the CIL and the socket is stiffer than interface section 15 between IIL 16 and trunk section 14.
- the mismatched stiffness between interfaces 15 and 19 arises in part because interface 19 comprises an overlap between the structure of leg 20 and the structure of socket 18, whereas interface 15 has no such overlapping structure.
- interfaces 15 and 19 may predispose the stent to unwanted in vivo behavior such as local kinking, occlusion, or bending.
- the lumen itself into which stent 10 is placed may vary in stiffness and/or geometry, may require the stent to conform to tortuous anatomy, and/or may require the stent to accommodate bending or longitudinal or transverse deformations, it is desirable that the stent mimic the lumen and respond coherently to applied deformation or loading.
- the interfaces between adjacent stent regions of different stiffness may also cause kinking, occlusion, or bending at the interface due to the drastic change in properties from one region to another.
- One aspect of the invention comprises a modular elongated stent for holding open a body lumen and for assembly in situ, the stent comprising at least a first component and a second component, the stent having an assembled configuration comprising the first component and the second component assembled together.
- the stent comprises an overlap region of the first component adapted to receive a portion of the second component in the assembled configuration, the overlap region having a first set of manipulation properties in the assembled configuration.
- One or more flexible stent regions are attached to the overlap region. Each flexible region has a second set of manipulation properties that differs from the first set of manipulation properties.
- the second set of manipulation properties includes greater flexibility, greater kink resistance, and/or less radial strength than the first set of manipulation properties.
- a mimic region is attached to the flexible region, the mimic region having a third set of manipulation properties that is essentially equivalent to the first set of manipulation properties.
- the different manipulation properties may be achieved by the flexible regions and mimic region having different metallurgical properties, such as a different annealing history, by each region having structural elements of differing cross-sectional areas, or by the mimic region having reinforcing material attached thereto.
- the reinforcing material may comprise an overlapping stent or one or more stiffening filaments.
- the modular stent may be a bifurcated modular stent in which the first component comprises a bifurcated component comprising a trunk section, a bifurcated section attached to the trunk section and having a first branch comprising a socket and a second branch comprising a fixed leg interface, and a fixed leg section depending from the fixed leg interface.
- the second component comprises a modular leg component adapted for insertion into the socket
- the overlap region comprises the socket
- the assembled configuration comprises the modular leg component inserted in the socket
- the mimic region comprises the fixed leg interface.
- the flexible regions comprise the trunk section and the fixed leg section.
- the mimic region may comprise a region of different stent architecture relative to the flexible region, such as different element heights, different numbers of elements in each hoop, different ratios of connected to unconnected elements, or a combination thereof.
- the invention also comprises a method for providing an elongated stent to hold open a designated portion of a body lumen having one or more curved regions. The method comprises first designing and fabricating the stent comprising one or more relatively stiff regions and one or more relatively flexible regions positioned to align with one of the curved regions of the body lumen when the stent is deployed within the body lumen. The relatively flexible regions have a stiffness less than the stiffness of the relatively stiff regions. Next, the stent is compressed, loaded within an introducer, and introduced into the body lumen. Finally, the stent is deployed from the introducer into the body lumen with each of the relatively flexible regions positioned in alignment with one of the curved regions of the body lumen.
- any of the stents of this invention may comprise at least one transition region between the stiff region and the flexible region having an intermediate set of manipulation properties, such as a gradient of manipulation properties, between the first set of manipulation properties and the second set of manipulation properties.
- the invention also comprises such a transition region between two regions having different manipulation properties wherein the transition region comprises a bridging material attached to the stent.
- the bridging material may comprise one or more filaments attached to the stent, such as wires welded to the stent.
- the invention also comprises an elongated stent for holding open a body lumen, the stent comprising at least a first longitudinal region having first metallurgical properties and a second longitudinal region having second metallurgical properties.
- the different metallurgical properties may be created by providing a differential annealed history between the regions.
- the first metallurgical properties may be created as the result of a first annealing history and the second metallurgical properties may be created as the result of a second annealing history.
- the invention comprises a method for providing kink resistance in an elongated stent adapted to hold open a body lumen, the stent having at least one stiff region with a first set of manipulation properties and at least one flexible region with a second set of manipulation properties different than the first set of manipulation properties, the second set of manipulation properties including at least one of: greater flexibility, greater kink resistance, or less radial strength than the first set of manipulation properties.
- the method comprises providing a mimic region having a third set of manipulation properties essentially equivalent to the first set of manipulation properties.
- Providing the mimic region may comprise modifying the mimic region relative to the flexible region by modifying its local metallurgical properties, providing members having a larger cross-sectional area, attaching reinforcing material, and/or modifying the stent architecture.
- Modifying the metallurgical properties may comprise heat treating the mimic region, such as by local laser heat treating.
- Modifying the metallurgical properties may in the alternative comprise providing a different annealing history for the mimic region.
- the invention also comprises providing an elongated stent for holding open a body lumen with a first longitudinal region having first metallurgical properties and a second longitudinal region having second metallurgical properties. The method comprises exposing the first longitudinal region to a first annealing history and exposing the second longitudinal region to a second annealing history.
- Providing the different annealing history may comprise providing a zoned annealing furnace having a relatively hotter region and a relatively cooler region, and annealing the stent by exposing the flexible region of the stent to the relatively hotter region of the furnace and exposing the stiff region of the stent to the relatively cooler region of the furnace.
- Another method of providing the different annealing history for the mimic region comprises mounting the stent during annealing on a mandrel having a relatively high thermal conductivity region and a relatively low thermal conductivity region or a relatively high heat sink region and a relatively low heat sink region.
- the relatively high heat sink region or relatively high thermal conductivity region of the mandrel is co-located with the stiff region of the stent, whereas relatively low heat sink region or relatively low thermal conductivity region of the mandrel is co-located with the flexible region of the stent. Because of the relatively different heat sink or thermal conductivity properties in different portions of the mandrel, the flexible region attains a higher annealing temperature or greater thermal input/load than the stiff region. The relatively high heat sink region or relatively high thermal conductivity region tends to conduct more heat away through the mandrel than the relatively low heat sink region or relatively low thermal conductivity region.
- the mandrel may be fabricated of a greater cross-sectional mass in the high heat sink region than in the low heat sink region.
- the mandrel may be fabricated, for example, of metal in the high conductivity region and ceramic in the low heat conductivity region.
- the invention also comprises a method for minimizing kinking of an elongated stent during introduction of the stent through the body lumen to a deployment location and during deployment of the stent at the deployment location.
- the stent has at least one stiff region with a first set of manipulation properties adjacent to at least one flexible region with a second set of manipulation properties different than the first set of manipulation properties.
- the second set of manipulation properties includes at least one of: greater flexibility, greater kink resistance, or less radial strength than the first set of manipulation properties.
- the method comprises first fabricating the stent with a transition region between the stiff region and each flexible region, the transition region having a third set of manipulation properties between the first set of manipulation properties and the second set of manipulation properties. Next, the stent is radially compressed and loaded into an introducer. Finally, the introducer is navigated through a tortuous body lumen while the transition region minimizes kinking of the stent resulting from the difference between the first set of manipulation properties and the second set of manipulation properties. The method may further comprise providing the transition region with a gradient from the first set of manipulation properties to the second set of manipulation properties.
- FIG. 1 is side view of a bifurcated modular stent-graft of the prior art in an assembled configuration, with the graft illustrated in a transparent format to show the stent scaffolding underneath.
- Fig. 2 is a side view of a bifurcated modular stent according to the present invention in an unassembled configuration, with the graft illustrated in a transparent format to show the stent scaffolding underneath.
- Fig. 3 is a side view of a portion of a stent showing a reinforced region and a transition region between the reinforced region and adjacent flexible regions.
- Fig. 4 is a schematic illustration of a stiff portion of a stent receiving a laser heat treatment.
- Fig. 5 is a schematic illustration of a stent undergoing an annealing step in a zoned annealing furnace, showing a graph of the temperature gradient in the furnace.
- Fig. 6 A is a cross-sectional illustration of a stent mounted on an exemplary mandrel having a variable conductive mass per unit length.
- Fig. 6B is a cross-sectional illustration of a stent mounted on an exemplary mandrel having two sections, each section differing in materials of construction and thermal conductivity.
- Fig. 6C is a cross-sectional illustration of a stent mounted on a mandrel and partially covered with a shielding collar.
- Fig. 7 is a side view of a portion of a wire stent having multiple wire diameters.
- Fig. 8 is a cross section of a tortuous lumen having a stent mounted therein.
- Fig. 9 A is a plan view of an exemplary stent embodiment cut along a line parallel to the stent axis and flattened, showing a stent having a modified stent architecture creating a stiff region and a transition region.
- Fig. 9B is a plan view of another exemplary stent embodiment cut along a line parallel to the stent axis and flattened, showing a stent having a modified stent architecture creating a stiff region and a transition region.
- Fig. 10 is a plan view of an exemplary stent embodiment where the stent has been cut along a line parallel to the stent axis and laid flat, showing a stent having a modified ratio of connected to unconnected apex sections to create a stiff region and a transition region.
- Fig. 11 is a side view schematic showing an exemplary stent being bent into an arc.
- Fig. 12 is a plan view of an exemplary diamond stent embodiment where the stent has been cut along a line parallel to the stent axis and laid flat, showing a stent having a gradient of box nodes between a stiff region having a lot of box nodes and a more flexible region having fewer box nodes.
- Fig. 13 is a longitudinal section of an exemplary braided stent having a polymer coating over the filaments of the stent to create a stiffened region, with a gradient number of spray coatings applied to provide a stiffness gradient between the relatively stiff and relatively flexible regions.
- a typical stent has a number of manipulation properties, such as stiffness or flexibility, radial strength, and kink resistance.
- "flexibility" or stiffness can be described in terms of the amount of force required to deform a stent into an arc.
- the force /required to bend tubular stent 2000 of a particular length into a given arc having a central angle and a given arc radius is a measure of the stent flexibility.
- a measure of the "kink resistance" of a stent is the kink angle ⁇ * or kink radius R* at which the stent kinks (when the tubular configuration becomes disrupted by crease 2200 as shown in Fig. 11).
- radial strength can be described generally as the resistance of a stent to radial compression.
- a stent with more radial strength exerts a greater outward radial force when compressed than does a stent with less radial strength.
- a shape memory expandable or resiliently compressible stent may have a fully expanded diameter and a constrained diameter as deployed within a lumen.
- the fully expanded diameter is the diameter to which the stent would expand without any constraint.
- radial strength can be expressed in terms of radial force or radial pressure.
- radial force is a valid measure of radial strength.
- radial pressure is a more appropriate measure of radial strength, so that the surface area of the stent is not a factor in the comparison.
- stent architecture there are general categories of architecture, such as for example, wound stent architecture, braided stent architecture, laser cut tube stent architecture, filamentary stent architecture, polygonal cell stent architecture, or zig-zag stent architecture.
- the various categories of stent architecture may overlap one another.
- one stent may comprise a filamentary, wound, polygonal cell stent architecture
- another stent may comprise a laser cut tube, polygonal cell stent architecture.
- “Filamentary” indicates that a stent comprises one or more filaments formed into the stent architecture
- a "laser cut tube” indicates that the stent comprises a tube that has been cut by a laser to form the geometric elements.
- stent architecture there are numerous broad categories of stent architecture, within each broad category there are a number of stent architectures that are considered “different" for the purposes of this specification and claims. For example, one region of a stent having a certain height geometric element may be considered a first stent architecture whereas another region of the same stent having a similar geometric element of a different height may be considered a second, different stent architecture. Other differences in architecture from one region to another may include, for example, the number of elements in each hoop or the ratio of connected to unconnected elements.
- stent architecture One component of stent architecture is geometric configuration.
- the "geometric configuration" refers to the geometric shape of the elements created within the stent.
- a stent having a filamentary, wound, polygonal cell stent architecture may have a geometric configuration wherein the cells are hexagonal and have a first size.
- Another stent having hexagonal cells of a second size still has the same geometric configuration as the stent having the hexagonal cells of the first size, but may still be said to have a different stent architecture.
- Stiffness (or flexibility), kink resistance, and radial strength are somewhat interrelated, in that for a given stent architecture, a design having a greater stiffness (and thus, lesser flexibility) generally has greater radial strength and less kink resistance as well.
- the three properties are interrelated, however, they are not necessarily proportionally or linearly related. That is, a first stent having 20% greater stiffness than a second stent may not necessarily have 20% greater radial strength or 20% less kink resistance, despite having some greater degree of radial strength and some lesser degree of kink resistance.
- a particular stent architecture may have, as an inherent function of its design, both greater stiffness and greater kink resistance as compared to another stent architecture.
- manipulator property is used herein to designate any one or more of these properties to facilitate discussion of this invention. Additionally, examples of different regions having different manipulation properties are discussed herein primarily in terms of variation in flexibility or stiffness. It should be understood, however, that whereas one stent region with respect to another may be characterized for brevity and convenience herein with respect only to differing stiffness, that region may also have a different radial strength and/or kink resistance as well.
- stent 20 is a modular bifurcated stent essentially identical to the stent shown in Fig. 1 except for a modification according to the present invention.
- Stent 20 shown in its unassembled configuration, has two modular components: bifurcated component 30 and modular leg component 40.
- Bifurcated component 30 comprises a trunk section 32, a branching section 34 and a fixed leg section 38.
- Branching section 34 has a first branch 33 comprising a socket 35 and a second branch 36 comprising a fixed leg interface 37, from which fixed leg section 38 depends.
- the assembled configuration of the stent 20 similar to the assembled configuration of stent 10 shown in Fig.
- mating portion 23 of modular leg component 40 inserts into socket 35, creating a stiff, overlap in region 22.
- overlap region 22 is not shown in an assembled configuration (with mating portion 23 of leg 40 inserted in socket 35) in Fig. 2, it should be understood that any reference herein to overlap region 22 and properties thereof refer to overlap region 22 in the assembled configuration of modular stent 20 (which resembles the assembled configuration of stent 10 shown in Fig. 1).
- Modular leg component 40 may mate with socket 35 in any known way to create such an overlap 22.
- Trunk section 32 and fixed leg section 38 comprise relatively flexible regions that are less stiff than overlap region 22.
- fixed leg interface 37 of stent 20 comprises a reinforced region that mimics the manipulation properties of overlap region 22 in accordance with the present invention.
- the purpose of reinforcing fixed leg interface 37 is to provide essentially the same manipulation properties in both the reinforced region and in the overlap region 22, it should be understood that in practice, due to variations in materials, assembly, or other factors, the actual manipulation properties of the overlap region and reinforced region may not be exactly the same.
- the manipulation properties of the two regions are "essentially equivalent" as claimed herein, however, in that fixed leg interface 37 reacts to loading in the same manner as overlap region 22.
- fixed leg interface 37 being essentially equivalent to overlap region 22 means that whatever slight differences may remain between the two regions, these differences are not significant enough to cause kinking merely as a result of any mismatch between the manipulation properties of the two sides.
- fixed leg interface 37 comprises reinforcing material attached to stent 20 in the form of an overlapping stent 50.
- reinforcing material shown in Fig. 2 comprises a discrete overlapping stent 50 having filaments 52 arranged in a pattern similar to overlap region 22, in an alternative embodiment the stiffening filaments 52 attached to stent 20 may be individual filaments rather than forming a discrete and separate stent. Other means for stiffening a region to mimic another region may also be used, as are described below.
- opposite branches 33 and 36 of branching section 34 respond more coherently to applied deformation or loading, mimic the lumen tortuosity better, and are more resistant to kinking, occlusion, or bending than in a stent such as stent 10 shown in Fig. 1 having mismatched manipulation properties on opposite branches.
- regions 137 and 123 just below interface 37 on leg 38 and mating portion 23 on leg 40, respectively, as shown in Fig. 2 become the next regions most likely to kink.
- the invention may further comprise regions 137 and 123 that have a greater stiffness than the remainder of leg 38 and leg 40, respectively, to prevent kinking in those regions.
- the stiffening in regions 137 and 123 may be effected by any of the methods discussed herein below.
- non-bifurcated modular stents also have overlap regions that may benefit from providing a mimic region elsewhere in the stent to match the manipulation properties of the overlapping region of the stent.
- Many stent embodiments have multiple regions with different manipulation properties, such as higher radial strength sections at the ends of a stent, that do not necessarily mimic other regions of the stent. Regardless of how or why such regions are created, another aspect of this invention addresses the discontinuity of manipulation properties that arises between adjacent stiff and flexible regions.
- a portion of a stent 21 having a relatively stiff, reinforced region 26 (or mimic region) and relatively more flexible regions 24, and further comprising a transition region 52 between reinforced region 26 and flexible regions 24.
- Transition regions 52 have intermediate manipulation properties, such as greater stiffness than in flexible regions 24 and less stiffness than in mimic region 26.
- Transition region 52 may comprise a gradually increasing stiffness (i.e., a gradient) from the flexible region 24 to the mimic region 26 as one travels along the length of transition region.
- an "intermediate" property of a transition section is a property between the two sections on either end of the transition section, with the property retaining the same value along the length of the transition section or gradually changing along the length of the transition section, as a gradient.
- transition region 52 may comprise a bridging material, such as a plurality of bridging filaments 54, attached to the stent.
- Stent 21 as shown in Fig. 3 is a wound stent, such as a wire stent comprising nitinol wires.
- filaments 54 may typically comprise metal wires, such as nitinol, welded to the stent, but may comprise other filaments known in the art such as polymeric filaments, and may be attached by other means such as adhesive bonding, suturing, or other methods known in the art.
- the bridging filaments create a "force bridge" that provides a stiffness gradient between the flexible region 24 and the reinforced region 26, dampening the step-change in stiffness.
- Other means for providing a transition region having intermediate manipulation properties or a gradient of manipulation properties may also be used, however, some examples of which are discussed herein later.
- stiffened region 137 on leg 38 may thus be a transition region of intermediate stiffening between the relatively greater stiffening desired for fixed leg interface 37 to mimic overlap region 22 and the normal flexibility of the remainder of leg 38.
- Stiffened region 123 therefore essentially mimics transition region 137, as region 123 stands alone without any corresponding region of greater stiffness on leg 40 to transition from, as the greater stiffness in overlap region 22 arises only after mating portion 23 is inserted in socket 35. Accordingly, region 123 may be referred to as a "transition mimic" region.
- the invention encompasses any stent having a transition region at an interface between regions of differing manipulation properties, such as a transition region between a stiff region and a flexible region to provide an intermediate stiffness, including a stiffness gradient.
- the transition region may comprise any of the various means for providing a transition, as disclosed herein.
- the invention includes providing kink resistance to a stent having regions of different manipulation properties by providing a transition region between the different regions.
- One means of providing regions having different manipulation properties within a stent is to provide regions having different metallurgical properties.
- the term metallurgical property shall have its common meaning, namely a characteristic of a metal including both how the metal was made and its physical and chemical characteristics. Different metallurgical properties, as used herein, are sufficiently different such that some measurable difference in manipulation properties can be seen in a typical use of the prosthesis of the present invention.
- a stiff region 126 of stent 100 may receive a localized heat treatment, such as from a beam 101 of laser device 102, that modifies the metallurgical properties in the stiff region to make it stiffer than the metallurgical properties in remaining flexible region 124.
- a high-power laser such as a continuous wave YAG or CO2 laser
- a temperature between 100°C and the melting point of the alloy controlled by varying the power of the beam and the exposure time (for example, on the order of approximately 1 second), may be sufficient to create the desired modification in metallurgical properties.
- Another method of providing different metallurgies to different regions is to anneal each region using different amounts of thermal input, thus providing a different annealing history for each region.
- stent 100 comprises a nitinol stent
- the annealing history of the metal sets the material and shape memory properties of the stent, as is well known.
- the different annealing histories may be provided in any number of ways, three exemplary methods of which are described herein.
- the effect of the annealing process on the wire of the stent is dependent upon the product of temperature and time, referred to herein as the "thermal input" .
- the thermal input typically takes the form of a time integral of temperature.
- the thermal input necessary to create the desired properties in a wire is dependent upon the material composition of the wire, the diameter of the wire, and the cold-working or strain history of the wire. Accordingly the precise temperatures and times of exposure vary depending upon the pre-annealed and desired annealed properties of the wire, but are known by those skilled in the art for specific wire grades commonly used and are readily determinable for new wire grades by experimentation.
- a zoned annealing furnace 150 such as is well-known in the art, is used to provide a relatively hotter region 152 and a relatively cooler region 154, as illustrated by the temperature/position curve shown in graph 170.
- Stent 100 is annealed on mandrel 160 by exposing flexible region 124 of the stent to relatively hotter region 152 of furnace 150 and exposing stiff region 126 of the stent to relatively cooler region 154 of the furnace. Annealing stent 100 for a predetermined amount of time with such exposures thus provides flexible region 124 with a greater thermal input than stiff region 126.
- stent 100 further comprises a transition region 125 having a gradient of metallurgical properties from flexible region 124 to mimic region 126.
- a 3-zone tube furnace marketed by Carbolite of Sheffield, England, can supply up to three different temperature zones, each 200 mm long, with a maximum differential of 30°C between each pair of adjacent zones. A 30°C temperature differential is sufficient to produce desired differences in manipulation properties across corresponding regions in the stent and gradient intermediate properties between the regions.
- a stent according to the present invention may be made with as many different zones as can be supplied by the annealing furnace, including more than 3 zones.
- Fig. 6A another method of providing a different annealing history for the stiff region 126 versus the flexible region 124, is to provide a hollow mandrel 170 that has a high heat sink region 172 and a low heat sink region 174.
- High heat sink region 172 has a relatively higher thermally conductive mass per unit length than low heat sink region 174. For example, as shown in Fig.
- high heat sink region 172 may comprise a region having a greater cross-sectional mass than the low heat sink region 174.
- High heat sink region 172 of the mandrel 170 is co-located with stiff region 126 of stent 100 and low heat sink region 174 of mandrel 170 is co-located with flexible region 124 of the stent.
- the thermal inertia provided by high heat sink region 172 as compared to low heat sink region 174 provides for a longer heat-up time in the high heat sink region that keeps stiff region 126 from experiencing as much thermal input as flexible region 124. Therefore, for example, although both regions 172 and 174 may ultimately reach the temperature of the annealing furnace by the end of the exposure time in the furnace, high heat sink region will reach that temperature at a slower rate, and thus the time integral of temperature is less in the high heat sink region than in the low heat sink region.
- Transition region 173 between the cross- sectional mass in the high heat sink region and the cross-sectional mass in the low heat sink region may comprise a gradual change in cross section to provide a thermal input gradient and a corresponding gradient of metallurgical properties in transition region 125 of stent 100.
- region 1172 of mandrel 1170 may have a higher thermal conductivity (greater specific heat capacity) than region 1174.
- region 1172 may be metal and region 1174 may be ceramic.
- the greater thermal conductivity of region 1172 as compared to region 1174 of mandrel 170 subjects flexible region 124 of stent 100 to a greater thermal input than stiff region 126, which creates the difference in annealed stiffness.
- the greater thermal conductivity allows a faster heat-up time and thus a greater time integral of temperature.
- stainless steel (alloy 304 SS) has a thermal conductivity of approximately 16 W/mK (Watts per meter per degree Kelvin), aluminum has a conductivity of approximately 147 W/mK, and toughened zirconia ceramic has a conductivity of approximately 2 W/mK.
- Mandrel 1170 thus may comprise a mix of adjacent ceramic and metallic regions.
- a threaded fitting or adhesively-bonded post 1175 may be provided at the interface between the regions, thus creating a transition region 1173 having an intermediate thermal conductivity that creates transition region 125 in stent 100.
- another material with an intermediate thermal conductivity could be used in the transition region.
- the geometry of post 1175 (or omission of the post altogether) may be manipulated as desired to tailor the thermal conductivity in the transition region between that of a step change and a gradient.
- a collar 175 of ceramic material may be placed over stiff region 126 of the stent on an all-metallic mandrel 177 during annealing, shielding the stent wire in stiff region 126 from some of the heat of the annealing furnace (or other annealing heat source known in the art).
- Collar 175 may have a variable thickness to provide a transition region 125 between flexible region 124 and stiff region 126.
- the variable thickness may be in the form of a gradient thickness as shown in Fig. 6C, or may comprise a step change in thickness.
- different collars having different thicknesses and/or different thermal conductivities may be used for the stiff region 126 and the transition region 125.
- the transition region may in the alternative be provided using multiple collars having different thicknesses and/or materials of construction or gradients thereof.
- Another way for providing regions of a stent having different manipulation properties is to vary the cross-sectional area of the structural elements of the stent.
- wire 202 in flexible region 224 may have a smaller diameter ⁇ than wire 204 in the stiff region 226 having a diameter d2.
- the metal left between the laser-cut slots may be thicker in the stiff region than in the flexible region.
- wire 206 in transition region 252 may be an intermediate thickness d 3 , or wires 202, 204, and 206 may together form a continuous wire having a diameter gradient between flexible region 224 and stiff region 226 decreasing from d4 to
- elongated stent 60 for holding open designated portion 62 of body lumen 64 having curved regions 66.
- Designated portion 62 has a length Li.
- Stent 60 has an expanded configuration for deployment within the body lumen as shown in Fig. 8, a compressed configuration (not shown) for introduction and transport within the lumen prior to deployment as is well-known in the art, and a length equivalent to length Li.
- Stent 60 has relatively stiff regions 68 and relatively flexible regions 70, each of the flexible regions positioned to align with one of the curved regions 66 of the body lumen 64 when stent 60 is deployed.
- relatively flexible regions 70 may be tailored by reducing the cross sectional area of the stent or by providing a higher annealing temperature, rather than tailoring relatively stiff regions 68 by increasing the cross-sectional area or providing a lower annealing temperature.
- Modifying stent architecture may also be used for providing regions of different manipulation properties within a stent to mimic another region of the stent and/or to provide kink resistance. For example, as shown in Figs.
- the stent may have a stent architecture comprising a recurrent pattern of geometric elements - struts 302 connected at apex sections 304 to form zigs 306 and zags 307, each zig comprising apex section 304i and the top half of connected struts 302i pointing in one direction (down, as shown in Fig. 9 A) and each zag comprising an apex section 304a and the bottom half of connected struts 302a pointing in the opposite direction (up, as shown in Fig. 9A).
- the elements are arranged in circumferential hoops 308 axially attached to one another.
- a hoop in a helical winding pattern may comprise one 360° helical revolution of the wire about the stent.
- Each zig in hoop 308f of flexible section 324 as shown in Fig. 9A has a zig height HF.
- Each hoop 308f has three zigs per hoop.
- Stiff region 326 has hoops 308s having a zig height Hs that is less than zig height HF and having six zigs 306s per hoop.
- Transition region 352 provides a gradient of manipulation properties between flexible region 324 and stiff region 326 by providing zigs of an intermediate zig height, namely in a gradient from Hti in hoop 308t ⁇ to Ht2 in hoop 308t2, and by providing an intermediate number of elements in each hoop, namely 4 zigs in hoop 308t ⁇ and 5 zigs in hoop 308t2.
- Fig. 9A shows both the height and number of zigs varied from the flexible to the stiff region, alternate embodiments may vary only a single variable, such as is shown in Fig. 9B.
- the included angle ⁇ between adjacent struts 302 also varies from hoop to hoop.
- the included angle ⁇ f in hoops 1308f is greater than the included angle at in hoop 1308t which, in turn, is greater than the included angle as in hoops 1308s.
- the included angle is another variable that may be varied, not only with respect to continuous wire zig-zag elements as illustrated in Figs.
- each hoop 308 may be connected to an axially adjacent hoop 308, such as with a suture 309 as shown in Fig. 10.
- a weld, an adhesive bond, or any means known in the art for joining axially adjacent elements may be provided.
- Transition region 352 provides a stiffness gradient between flexible region 324 and stiff region 326 by providing an intermediate ratio of connected to unconnected elements, namely a ratio gradient comprising 2:2 in hoop 308t ⁇ and 3:1 in hoop 308t2.
- a single stent embodiment may incorporate variations of any combination of the above variables.
- a zig-zag wire stent architecture other stent architectures having elements with a different geometry may comprise regions of different size elements, different numbers of elements per hoop, different angles between structural members, or different ratios of connected elements, to provide similar variations in manipulation properties.
- the stiff and the flexible regions have the same general stent geometry. That is, although certain features of the architecture may be changed, such as zig height, number of zigs, or ratio of connected to unconnected zigs, the general zig-zag geometry is still maintained.
- other stent designs such as those described in application 09/442,165, filed on November 16, 1999, and assigned to the common assignee of this invention, incorporated herein by reference, two entirely different filamentary stent geometries may be linked together, such as a braided stent geometry and a zig-zag stent geometry. Each geometry has respective manipulation properties, and thus the interface between regions of different geometry, in certain configurations, may present a distinct step change.
- the present invention of providing a transition region between a relatively stiff and a relatively flexible region may be incorporated into such a design, such as by attaching wires as force bridges between the different stent geometry regions.
- Another broad category of stent architecture is described in co-pending patent application [CIP of U.S. Serial No. 09/052,214] to Colgan et al, (hereinafter "the Colgan Application") assigned to the assignee of the present invention, and incorporated herein by reference.
- the "diamond stent" 3000 described in the Colgan Application comprises a pattern of diamond-shaped elements 3002.
- the Colgan Application also discloses box nodes 3004 that may be placed at one or more interfaces 3006 between adjacent diamond elements.
- box nodes 3004 may be used for providing local stiffness in one region as compared to another, such as greater stiffness at the ends than in the middle.
- Interfaces 3006 without box nodes comprise "empty interfaces" 3007.
- the present invention of modifying the stent architecture to provide a transition region between areas of different stiffness may be applied to the invention described in the Colgan Application, as may the present invention of providing a stiffened region to mimic another region of a stent.
- a localized region 3008 is strengthened with a greater ratio of box nodes 3004 to empty interfaces 3007 as compared to another region 3009
- a transition region 3010 may contain an intermediate ratio of box nodes to empty interfaces or a gradient in the ratio. As is shown in Fig.
- region 3008 has a box node at every circumferential interface 3006, or a ratio of 4:0 box nodes to empty interfaces 3007, whereas region 3009 has only one box node per circumferential revolution, or a ratio of 1:3 box nodes to empty interfaces.
- Transition region 3010 contains an intermediate ratio of box nodes 3004 to empty interfaces 3007 in the form of a gradient of 3: 1 to 2:2 box nodes to empty interfaces between from region 3008 with an infinite ratio and region 3009 with a 1:3 ratio.
- Region 3008 may be a mimic region that is stiffened using box nodes to provide stiffness and/or other manipulation properties that are essentially equivalent to the stiffness and/or other manipulation properties of another region of the stent.
- the Pinchuk patent describes a process for coating a stent with a polymer such that crossing or adjacent wire filaments are bound to each other by the polymer without the polymer occluding interstices between the filaments.
- the polymer is applied to the stent in a plurality of spray coatings, wherein an increase in the number of spray coatings increases the radial strength of the stent.
- the Pinchuk patent may be applied to selected sections of a stent to create stiffened regions and more flexible regions by applying the polymer coating in the stiff regions and no coating (or a lesser number of spray coats) in the flexible regions.
- the Pinchuk patent may further be applied to create transition regions between the relatively stiff and flexible regions by applying an intermediate number of spray coatings to the transition region between the flexible and stiff regions.
- a gradient transition region may be provided by creating a gradient number of coatings.
- stiffened region 134 comprises four layers of polymer coating 136i-iv, whereas flexible region 138 comprises no coating layers.
- Transition region 137 comprises an intermediate number of layers of polymer coating from one layer 136i to three layers 136i-iii. Such layers may be applied by masking the region of the stent not to be coated during spray coating of each region.
- the polymer stiffening method of stiffening is particularly advantageous for stiffening braided stents or for affixing adjacent apices of zig-zag stents as disclosed in the Pinchuk patent
- the polymer stiffening method may be applied to any stent architecture known in the art having overlapping, touching, or nearly-touching filaments desired to be bonded together with some degree of stiffness.
- the polymer coating is applicable to stents having only near-contact points, a near-contact point being defined as a point where stent filaments do not actually cross or contact one another, but are close enough that the polymer can bridge the distance between the filaments.
- filamentary stent architectures have some degree of interstitial space defined by the filaments.
- the interstitial space may be in the form of discrete closed cells bounded on all sides by filamentary structure, or a continuous open space connected by the gaps between near-contact points.
- the polymer coating method of the present invention does not substantially occlude the interstitial space. That is, a majority of the interstitial space still remains after the coating process, even if the coating process may segment a formerly continuous open space into discrete cells by closing gaps between near- contact points.
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60014149T DE60014149T2 (en) | 1999-11-16 | 2000-11-16 | MODULAR, ENDOLUMINARY STENT WITH ADJUSTED STIFFNESS ZONES |
JP2001537659A JP2003513747A (en) | 1999-11-16 | 2000-11-16 | Modular endoluminal stent with aligned rigid regions |
CA002386946A CA2386946A1 (en) | 1999-11-16 | 2000-11-16 | Modular endoluminal stent having matched stiffness regions |
AU16118/01A AU776435B2 (en) | 1999-11-16 | 2000-11-16 | Modular endoluminal stent having matched stiffness regions |
EP00978682A EP1229863B1 (en) | 1999-11-16 | 2000-11-16 | Modular endoluminal stent having matched stiffness regions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/442,192 | 1999-11-16 | ||
US09/442,192 US6610087B1 (en) | 1999-11-16 | 1999-11-16 | Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001035863A1 WO2001035863A1 (en) | 2001-05-25 |
WO2001035863A9 true WO2001035863A9 (en) | 2002-09-26 |
Family
ID=23755871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/031374 WO2001035863A1 (en) | 1999-11-16 | 2000-11-16 | Modular endoluminal stent having matched stiffness regions |
Country Status (7)
Country | Link |
---|---|
US (3) | US6610087B1 (en) |
EP (1) | EP1229863B1 (en) |
JP (1) | JP2003513747A (en) |
AU (1) | AU776435B2 (en) |
CA (1) | CA2386946A1 (en) |
DE (1) | DE60014149T2 (en) |
WO (1) | WO2001035863A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
US9427340B2 (en) | 2004-12-14 | 2016-08-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US9492297B2 (en) | 2006-09-12 | 2016-11-15 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6258116B1 (en) * | 1996-01-26 | 2001-07-10 | Cordis Corporation | Bifurcated axially flexible stent |
US8728143B2 (en) | 1996-06-06 | 2014-05-20 | Biosensors International Group, Ltd. | Endoprosthesis deployment system for treating vascular bifurcations |
US7686846B2 (en) | 1996-06-06 | 2010-03-30 | Devax, Inc. | Bifurcation stent and method of positioning in a body lumen |
US7238197B2 (en) | 2000-05-30 | 2007-07-03 | Devax, Inc. | Endoprosthesis deployment system for treating vascular bifurcations |
US8172897B2 (en) | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US10028851B2 (en) | 1997-04-15 | 2018-07-24 | Advanced Cardiovascular Systems, Inc. | Coatings for controlling erosion of a substrate of an implantable medical device |
US7807211B2 (en) * | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US6325822B1 (en) | 2000-01-31 | 2001-12-04 | Scimed Life Systems, Inc. | Braided stent having tapered filaments |
US6805898B1 (en) * | 2000-09-28 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Surface features of an implantable medical device |
US8372139B2 (en) | 2001-02-14 | 2013-02-12 | Advanced Bio Prosthetic Surfaces, Ltd. | In vivo sensor and method of making same |
US6660034B1 (en) * | 2001-04-30 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Stent for increasing blood flow to ischemic tissues and a method of using the same |
US6695920B1 (en) | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
US6565659B1 (en) * | 2001-06-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Stent mounting assembly and a method of using the same to coat a stent |
US7147661B2 (en) | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
US7029494B2 (en) * | 2002-02-08 | 2006-04-18 | Scimed Life Systems, Inc. | Braided modular stent with hourglass-shaped interfaces |
US7004964B2 (en) * | 2002-02-22 | 2006-02-28 | Scimed Life Systems, Inc. | Apparatus and method for deployment of an endoluminal device |
US7887573B2 (en) * | 2002-02-22 | 2011-02-15 | Boston Scientific Scimed, Inc. | Method and apparatus for deployment of an endoluminal device |
US7396539B1 (en) * | 2002-06-21 | 2008-07-08 | Advanced Cardiovascular Systems, Inc. | Stent coatings with engineered drug release rate |
US7335265B1 (en) | 2002-10-08 | 2008-02-26 | Advanced Cardiovascular Systems Inc. | Apparatus and method for coating stents |
DE60231843D1 (en) | 2002-11-08 | 2009-05-14 | Jacques Seguin | ENDOPROTHESIS FOR VESSEL FORKING |
US7704276B2 (en) * | 2002-11-15 | 2010-04-27 | Synecor, Llc | Endoprostheses and methods of manufacture |
US7074276B1 (en) | 2002-12-12 | 2006-07-11 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US7025779B2 (en) | 2003-02-26 | 2006-04-11 | Scimed Life Systems, Inc. | Endoluminal device having enhanced affixation characteristics |
US20040225349A1 (en) * | 2003-05-09 | 2004-11-11 | Thistle Robert C. | Eversible locking mechanism for modular stents |
US20040254628A1 (en) * | 2003-06-13 | 2004-12-16 | Patrice Nazzaro | One-branch stent-graft for bifurcated lumens |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US7704544B2 (en) * | 2003-10-07 | 2010-04-27 | Advanced Cardiovascular Systems, Inc. | System and method for coating a tubular implantable medical device |
US7763011B2 (en) * | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
JP2007529273A (en) * | 2004-03-15 | 2007-10-25 | メドトロニック ヴァスキュラー インコーポレイテッド | Stent resistant to radial crush |
US20070292478A1 (en) | 2004-08-30 | 2007-12-20 | Popowski Youri | Medical Implant Provided with Inhibitors of Atp Synthesis |
GB0419954D0 (en) * | 2004-09-08 | 2004-10-13 | Advotek Medical Devices Ltd | System for directing therapy |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
KR101354189B1 (en) | 2005-02-04 | 2014-01-20 | 에이엠에스 리서치 코포레이션 | Surgical implants and related methods and systems |
US20060217760A1 (en) * | 2005-03-17 | 2006-09-28 | Widomski David R | Multi-strand septal occluder |
US20060259127A1 (en) * | 2005-05-10 | 2006-11-16 | Deborah Tolomeo | Apparatus and method for anchoring endoluminal prostheses in tortuous geometries |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US20070129791A1 (en) * | 2005-12-05 | 2007-06-07 | Balaji Malur R | Stent with integral filter |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8003156B2 (en) | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9539124B1 (en) | 2006-11-21 | 2017-01-10 | Seshadri Raju | Venous stent |
US8636791B1 (en) | 2006-11-21 | 2014-01-28 | Seshadri Raju | Venous stent |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US20100274348A1 (en) * | 2007-12-19 | 2010-10-28 | Invatec Technology Center Gmbh | Modular Stent Assembly |
KR100988816B1 (en) * | 2008-01-29 | 2010-10-20 | 신경민 | A stent |
CA2723810C (en) * | 2008-05-07 | 2015-06-30 | Guided Delivery Systems, Inc. | Deflectable guide |
US20100010533A1 (en) * | 2008-07-11 | 2010-01-14 | Cook Incorporated | Variable strength embolization coil |
US9149377B2 (en) * | 2008-10-10 | 2015-10-06 | Veryan Medical Ltd. | Stent suitable for deployment in a blood vessel |
US20100174357A1 (en) * | 2009-01-07 | 2010-07-08 | Lemaitre Vascular, Inc. | Vascular Prosthesis of Varying Flexibility |
WO2010085456A1 (en) | 2009-01-20 | 2010-07-29 | Guided Delivery Systems Inc. | Anchor deployment devices and related methods |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
JP2012525239A (en) | 2009-05-01 | 2012-10-22 | エンドロジックス、インク | Transcutaneous methods and devices for treating dissociation (priority information and incorporation by reference) |
WO2011017123A2 (en) | 2009-07-27 | 2011-02-10 | Endologix, Inc. | Stent graft |
EP2496189A4 (en) | 2009-11-04 | 2016-05-11 | Nitinol Devices And Components Inc | Alternating circumferential bridge stent design and methods for use thereof |
US9649211B2 (en) | 2009-11-04 | 2017-05-16 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design and methods for use thereof |
US8864811B2 (en) | 2010-06-08 | 2014-10-21 | Veniti, Inc. | Bi-directional stent delivery system |
US9301864B2 (en) | 2010-06-08 | 2016-04-05 | Veniti, Inc. | Bi-directional stent delivery system |
US9233014B2 (en) | 2010-09-24 | 2016-01-12 | Veniti, Inc. | Stent with support braces |
WO2012068298A1 (en) | 2010-11-17 | 2012-05-24 | Endologix, Inc. | Devices and methods to treat vascular dissections |
DE102012100839A1 (en) * | 2012-02-01 | 2013-08-01 | Jotec Gmbh | Intraluminal vascular prosthesis |
CN104203151A (en) * | 2012-02-14 | 2014-12-10 | 尼奥格拉夫特科技公司 | Kink resistant graft devices and related systems and methods |
US9907684B2 (en) | 2013-05-08 | 2018-03-06 | Aneuclose Llc | Method of radially-asymmetric stent expansion |
US9468545B2 (en) * | 2014-04-04 | 2016-10-18 | W. L. Gore & Associates, Inc. | Bifurcated graft device |
US9510976B2 (en) * | 2014-04-29 | 2016-12-06 | Abbott Cardiovascular Systems Inc. | Devices and methods for treatment of the Eustachian tube and sinus cavity |
US9545263B2 (en) | 2014-06-19 | 2017-01-17 | Limflow Gmbh | Devices and methods for treating lower extremity vasculature |
EP3653177B1 (en) | 2015-01-11 | 2021-09-01 | Ascyrus Medical, LLC | Hybrid device for surgical aortic repair |
CA2978599C (en) | 2015-03-05 | 2022-09-06 | Ancora Heart, Inc. | Devices and methods of visualizing and determining depth of penetration in cardiac tissue |
BR112018004561A2 (en) * | 2015-09-09 | 2018-10-09 | Frid Mind Tech | implantable permanent filter assembly |
EP3585320B1 (en) | 2017-02-24 | 2022-07-27 | Bolton Medical, Inc. | Delivery system for radially constricting a stent graft |
ES2863978T3 (en) | 2017-02-24 | 2021-10-13 | Bolton Medical Inc | System for radially constricting a stent graft |
WO2018156848A1 (en) | 2017-02-24 | 2018-08-30 | Bolton Medical, Inc. | Vascular prosthesis with crimped adapter and methods of use |
CN110730634A (en) | 2017-04-10 | 2020-01-24 | 林弗洛公司 | Apparatus and method for treating the vasculature of a lower limb |
WO2019060816A2 (en) | 2017-09-25 | 2019-03-28 | Aortica Corporation | Systems, devices, and methods for coupling a prosthetic implant to a fenestrated body |
JP7168566B2 (en) | 2017-10-31 | 2022-11-09 | ボルトン メディカル インコーポレイテッド | Distal torque component, delivery system and method of use |
US11364134B2 (en) * | 2018-02-15 | 2022-06-21 | Vesper Medical, Inc. | Tapering stent |
CN112955207A (en) | 2018-10-09 | 2021-06-11 | 林弗洛公司 | Apparatus and method for catheter alignment |
JP2022518927A (en) * | 2019-02-01 | 2022-03-17 | ボルトン メディカル インコーポレイテッド | Expandable luminal stent and usage |
EP4051174A4 (en) | 2019-11-01 | 2023-11-22 | LimFlow GmbH | Devices and methods for increasing blood perfusion to a distal extremity |
CA3158078A1 (en) * | 2019-11-12 | 2021-05-20 | Microvention, Inc. | Stent delivery system and method |
US10881541B1 (en) | 2020-05-01 | 2021-01-05 | Krishna Rocha-Singh | Systems and methods for treating venous compression/obstruction syndromes |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2683449A1 (en) | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
US5540712A (en) * | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
US5609627A (en) | 1994-02-09 | 1997-03-11 | Boston Scientific Technology, Inc. | Method for delivering a bifurcated endoluminal prosthesis |
NL9500094A (en) * | 1995-01-19 | 1996-09-02 | Industrial Res Bv | Y-shaped stent and method of deployment. |
US5683449A (en) * | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
US5824037A (en) * | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
JP2001502605A (en) * | 1996-01-30 | 2001-02-27 | メドトロニック,インコーポレーテッド | Articles and methods for making a stent |
US5649949A (en) | 1996-03-14 | 1997-07-22 | Target Therapeutics, Inc. | Variable cross-section conical vasoocclusive coils |
US5868780A (en) | 1996-03-22 | 1999-02-09 | Lashinski; Robert D. | Stents for supporting lumens in living tissue |
CA2199890C (en) | 1996-03-26 | 2002-02-05 | Leonard Pinchuk | Stents and stent-grafts having enhanced hoop strength and methods of making the same |
NZ331269A (en) * | 1996-04-10 | 2000-01-28 | Advanced Cardiovascular System | Expandable stent, its structural strength varying along its length |
US5755773A (en) | 1996-06-04 | 1998-05-26 | Medtronic, Inc. | Endoluminal prosthetic bifurcation shunt |
US5807404A (en) * | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US5827588A (en) | 1996-11-18 | 1998-10-27 | Ingersoll-Rand Company | Workpiece having a laser heat-treated surface formed by a small diameter bore extending in workpiece |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5817126A (en) | 1997-03-17 | 1998-10-06 | Surface Genesis, Inc. | Compound stent |
WO1998047447A1 (en) | 1997-04-23 | 1998-10-29 | Dubrul William R | Bifurcated stent and distal protection system |
US5836966A (en) | 1997-05-22 | 1998-11-17 | Scimed Life Systems, Inc. | Variable expansion force stent |
AUPO700897A0 (en) | 1997-05-26 | 1997-06-19 | William A Cook Australia Pty Ltd | A method and means of deploying a graft |
CA2235911C (en) | 1997-05-27 | 2003-07-29 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
FR2764794B1 (en) * | 1997-06-20 | 1999-11-12 | Nycomed Lab Sa | EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS |
FR2765097B1 (en) | 1997-06-25 | 1999-08-06 | Braun Celsa Sa | IMPLANT WITH VARIABLE CRUSHING RESISTANCE, IMPLANTABLE IN AN ANATOMICAL CONDUIT |
US6165195A (en) * | 1997-08-13 | 2000-12-26 | Advanced Cardiovascylar Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6059822A (en) | 1997-08-22 | 2000-05-09 | Uni-Cath Inc. | Stent with different mesh patterns |
US6179867B1 (en) | 1998-01-16 | 2001-01-30 | Advanced Cardiovascular Systems, Inc. | Flexible stent and method of use |
FR2775182B1 (en) * | 1998-02-25 | 2000-07-28 | Legona Anstalt | DEVICE FORMING INTRACORPOREAL ENDOLUMINAL ANDOPROTHESIS, IN PARTICULAR AORTIC ABDOMINAL |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6730117B1 (en) | 1998-03-05 | 2004-05-04 | Scimed Life Systems, Inc. | Intraluminal stent |
US6520983B1 (en) | 1998-03-31 | 2003-02-18 | Scimed Life Systems, Inc. | Stent delivery system |
US6273909B1 (en) | 1998-10-05 | 2001-08-14 | Teramed Inc. | Endovascular graft system |
US6325820B1 (en) | 1998-11-16 | 2001-12-04 | Endotex Interventional Systems, Inc. | Coiled-sheet stent-graft with exo-skeleton |
AU774924B2 (en) | 1999-01-22 | 2004-07-15 | W.L. Gore & Associates, Inc. | Covered endoprosthesis and delivery system |
-
1999
- 1999-11-16 US US09/442,192 patent/US6610087B1/en not_active Expired - Fee Related
-
2000
- 2000-11-16 JP JP2001537659A patent/JP2003513747A/en active Pending
- 2000-11-16 AU AU16118/01A patent/AU776435B2/en not_active Ceased
- 2000-11-16 EP EP00978682A patent/EP1229863B1/en not_active Expired - Lifetime
- 2000-11-16 DE DE60014149T patent/DE60014149T2/en not_active Expired - Lifetime
- 2000-11-16 WO PCT/US2000/031374 patent/WO2001035863A1/en active IP Right Grant
- 2000-11-16 CA CA002386946A patent/CA2386946A1/en not_active Abandoned
-
2003
- 2003-07-02 US US10/612,110 patent/US7214241B2/en not_active Expired - Fee Related
-
2007
- 2007-04-13 US US11/735,180 patent/US7722664B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9427340B2 (en) | 2004-12-14 | 2016-08-30 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US9492297B2 (en) | 2006-09-12 | 2016-11-15 | Boston Scientific Scimed, Inc. | Multilayer balloon for bifurcated stent delivery and methods of making and using the same |
US8932340B2 (en) | 2008-05-29 | 2015-01-13 | Boston Scientific Scimed, Inc. | Bifurcated stent and delivery system |
Also Published As
Publication number | Publication date |
---|---|
EP1229863A1 (en) | 2002-08-14 |
DE60014149D1 (en) | 2004-10-28 |
AU1611801A (en) | 2001-05-30 |
US20040106981A1 (en) | 2004-06-03 |
DE60014149T2 (en) | 2005-11-17 |
EP1229863B1 (en) | 2004-09-22 |
US6610087B1 (en) | 2003-08-26 |
JP2003513747A (en) | 2003-04-15 |
WO2001035863A1 (en) | 2001-05-25 |
CA2386946A1 (en) | 2001-05-25 |
US20070185563A1 (en) | 2007-08-09 |
AU776435B2 (en) | 2004-09-09 |
US7214241B2 (en) | 2007-05-08 |
US7722664B2 (en) | 2010-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7214241B2 (en) | Endoluminal stent having a matched stiffness region and/or a stiffness gradient and methods for providing stent kink resistance | |
EP1255507B1 (en) | Stent matrix | |
EP1435878B1 (en) | System for fixation of endoluminal devices | |
EP1342455B1 (en) | Expandable supportive branched endoluminal grafts | |
US6890350B1 (en) | Combination self-expandable, balloon-expandable endoluminal device | |
CA2361067C (en) | Covered stent with encapsulated ends | |
US7326244B2 (en) | Intravascular folded tubular endoprosthesis | |
US6695877B2 (en) | Bifurcated stent | |
JP4198785B2 (en) | Bifurcated stent graft | |
EP1337198B1 (en) | Endoluminal device having superelastic and plastically deformable sections | |
WO2001037892A1 (en) | Thin-layered, endovascular, polymer-coated stent device | |
WO2004075791A1 (en) | Endoluminal device having enhanced affixation characteristics | |
JP2009526572A (en) | Highly flexible stent and manufacturing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2386946 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000978682 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 537659 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 16118/01 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000978682 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/7-7/7, DRAWINGS, REPLACED BY NEW PAGES 1/9-9/9; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000978682 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 16118/01 Country of ref document: AU |